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Arf family proteins are critical regulators of intracellular trafficking and actin cytoskeleton dynamics. To carry
out their cellular functions, Arf family proteins interact with various effectors that differ in nature and structure.
Understanding how these proteins interact with structurally different partners and are distinguished by
specific effectors while being closely related requires a structural characterization and comparison of the
various Arf family:effector complexes. Recent structural reports of Arf and Arl proteins in complex with
different downstream effectors shed new light on general and specific structural recognition determinants
characteristic of Arf family proteins.Introduction
Arf family proteins are Ras-like small GTP-binding proteins of
20 kDa, which consist of about thirty members that can be
divided into three groups: the Arfs, the Arf-like (Arls), and the
SARs (Kahn et al., 2006). The Arfs (ADP-ribosylation factor)
comprise six proteins in mammals, which play regulatory func-
tions in vesicle formation and trafficking as well as in actin cyto-
skeleton dynamics (D’Souza-Schorey andChavrier, 2006;Myers
and Casanova, 2008). Their name comes from their ability to
function as cofactors for cholera-toxin-catalyzed ADP-ribosyla-
tion of the a-subunit of heterotrimeric G proteins, Gs, in cell-
free biochemical assays (Kahn and Gilman, 1986). Of note, this
ability is not shared by Arls and SARs. ARF1, ARF2 (a pseudo-
gene in human), and ARF3 that are >96% identical comprise
the class I Arfs; class II Arfs consist of ARF4 and ARF5 (90%
identical to each other and 80% identical to class I Arfs), while
ARF6 (64%–69% identical to the other Arfs) is the sole member
of class III and also the most divergent member of the Arfs. Of
note, Arls, which comprise the largest group with twenty
members in humans, are not a phylogenetically coherent group
(Kahn et al., 2006). The precise biological role of each Arl remains
largely unknown, and available data rather support the conclu-
sion that this group of proteins is functionally diverse, with
some important roles in tubulin folding, membrane trafficking
and ciliogenesis, (Burd et al., 2004; Kahn et al., 2006; Gillingham
and Munro, 2007). Finally, SARs (two members in human called
SAR1A and SAR1B) are functionally related to the Arfs ibecause
they associate to membranes in the early secretory pathway and
initiate vesicle budding through interaction with the COPII coat
(Gillingham and Munro, 2007).
Arf family proteins are implicated in a variety of cellular func-
tions, which are mediated by effector proteins that specifically
recognize and bind to the GTP-bound form of their cognate Arf
family protein(s). The characteristic structural organization of
Arf family proteins as compared with other small G proteins
has several consequences for effector interaction. Indeed, Arf
family proteins possess a unique N-terminal extension that folds
as an amphipatic helix and most of them a glycine residue at1552 Structure 18, December 8, 2010 ª2010 Elsevier Ltd All rights reposition 2 (see Figure S1 available online), which is posttransla-
tionally modified by the addition of a myristoyl fatty acid group.
Both the N-terminal amphipatic helix and the myristoyl group
are critical for interaction of Arfs with membranes (Antonny
et al., 1997; Liu et al., 2009, 2010). This N-terminal membrane-
anchoring extension is connected to the G domain by a short
flexible linker, imposing the Arf family proteins to be close to
the bilayer surface. Such a proximity with the membrane prob-
ably imposes a constraint orientation to the Arf family proteins
and also to their cellular partners, including downstream effec-
tors, that should impact their mode of binding (Isabet et al.,
2009; Liu et al., 2010). This contrasts with the situation in Rab
and Rho families, in which the connecting region consists in
a longer C-terminal flexible linker, ending in a membrane-
anchoring isoprenylated motif that can potentially extend far
from the bilayer surface (Gillingham andMunro, 2007). Although,
like all G proteins, Arf family proteins exhibit the classical GDP/
GTP cycle characterized by structural changes in the so-called
switch 1 and switch 2 regions, they depart in having two addi-
tional nucleotide-sensitive regions: the interswitch and the
N-terminal helix (Pasqualato et al., 2002). In the GDP-bound
form, the interswitch, which consists of two connected b strands
between switches 1 and 2, adopts an atypical retracted position
and forms a pocket to which the myristoylated N-terminal helix
folds back. In the GTP-bound form, the interswitch, which
undergoes a two-residues register shift, features the classical
position observed in other small G proteins. In this conformation,
the interswitch obstructs the pocket where the myristoylated
N-terminal helix binds, which is then free to associate with
membranes through hydrophobic and lipid interactions. Of
note, switches 1 and 2 combined with the interswitch and the
N-terminal helix form a large surface on one face of the Arf family
proteins. Thus, the switch region, which represents the primary
binding site for the effectors to discriminate between the GDP-
and GTP-bound states (Vetter and Wittinghofer, 2001), is larger
in Arf family proteins than in other small G proteins. Such a struc-
tural feature is exploited by downstream effectors to interact with
their cognate Arf family protein(s).served
Figure 1. Structure Gallery of Arf
Family:Effector Complexes
The seven known Arf family:effector complex
crystal structures are shown with the Arf family
proteins in the same orientation and the switch
regions highlighted in dark gray. ARF1:GGAN-GAT
(PDB code 1J2J) (Shiba et al., 2003); ARL1:
golgin-245GRIP (PDB codes 1UPT and 1R4A)
(Panic et al., 2003) and (Wu et al., 2004);
ARF1:ARHGAP21ArfBD (PDB code 2J59) (Me´ne´-
trey et al., 2007); ARF6:CTA1 (PDB code 2A5D)
(O’Neal et al., 2005); ARL2:PDEd (PDB code
1KSH) (Hanzal-Bayer et al., 2002); ARL2:BART
(PDB code 3DOE) (Zhang et al., 2009); and ARF6:
JIP4 (PDB code 2W83) (Isabet et al., 2009).
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not exhaustive, reveals a heterogenous family of proteins with
various functions and structures. In Arf family proteins, the high
degree of sequence and structural similarities between the
different groups (such as between Arfs and Arls), and further
more within the same group (for instance within the Arfs), raise
the issue of what determine(s) effector specificity. Indeed, it
is unclear how effectors such as FIP3/FIP4 (Rab11 family-
interacting proteins 3 and 4) or JIP3/JIP4 (JNK-interacting
proteins 3 and 4) can discriminate between ARF1 and ARF6
(Montagnac et al., 2009; Schonteich et al., 2007) that share
78% sequence identity in the switch regions and exhibit virtually
identical GTP-bound form structure (Pasqualato et al., 2001).
Here, based on the available crystal structures of Arf family
proteins in complex with different effectors, we detail essential
structural features of Arf family:effector complexes and provide
a framework to the structural understanding of Arf family:effector
specificity.
Arf Family:Effector Complexes: A Structural Overview
To date, seven structures of Arfs or Arls in complex with their
downstream effectors (or their Arf-binding domain) have been
reported including ARF1:GGA1, ARF1:ARHGAP21, ARF6:CT,
ARF6:JIP4, ARL1:golgin-245, ARL2:PDEd, and ARL2:BART
(Hanzal-Bayer et al., 2002; Isabet et al., 2009; Me´ne´trey et al.,
2007; O’Neal et al., 2005; Panic et al., 2003; Shiba et al., 2003;
Wu et al., 2004; Zhang et al., 2009) (see Figure 1).
ARF1:GGA1
Golgi-localized gamma-ear containing ARF-binding (GGA)
proteins are monomeric clathrin-associated adaptor proteins
involved in the trafficking of cargo between the trans-Golgi
network (TGN) and endosomes (Dell’Angelica et al., 2000; Hirst
et al., 2000; Bonifacino, 2004). GGAs comprise three folded
domains: a N-terminal VHS (Vps27/Hrs/Stam) domain, which
binds cargo proteins; a GAT (GGA and Tom1) domain that bindsStructure 18, December 8, 2010 ªArfs and ubiquitin; and a C-terminal GAE
(g-adaptin ear) domain with homology
with the C-terminal appendage ear
domain of the g subunit of the tetrameric
AP-1 clathrin adaptor complex, which
binds various accessory proteins. In
addition, a proline-rich hinge region with
several clathrin-binding sites connects
the GAT and GAE domains. The GATdomain has been identified as the key region interacting with
Arf-GTP and serves as a molecular anchor of GGAs to TGN
membranes. The crystal structure of a complex of ARF1-GTP
with the GAT domain of GGA1 (ARF1:GGA1N-GAT) shows that
the N-terminal region of the GAT domain, which is disordered
on its own, forms a helix-loop-helix structure when bound to
ARF1-GTP (Shiba et al., 2003) (Figure 1). The Arf-binding surface
of N-GAT is on one side of both helices and is predominantly
hydrophobic with several polar residues. The two helices of N-
GAT are positioned against the b sheet of the interswitch and
interact with switches 1 and 2 of ARF1-GTP.
ARF1:ARHGAP21
ARHGAP21 (also named ARHGAP10) is a Rho family GTPase-
activating protein (RhoGAP) that is recruited by ARF1-GTP to
the Golgi complex, where it regulates F-actin dynamics by
controlling Cdc42 and Arp2/3 complex actin nucleating activity
(Dubois et al., 2005). The Arf-binding domain (ArfBD) of ARH-
GAP21 that interacts with the GTP-bound forms of ARF1 and
ARF6 (and ARF5 [P. Chavrier, unpublished data]) consists of
a PH domain and an adjacent C-terminal a helix (aCter) (Dubois
et al., 2005; Me´ne´trey et al., 2007). The crystal structure of
ARF1:ARHGAP21ArfBD reveals that both the PH domain and
the aCter helix contact ARF1-GTP through its switch regions
(Figure 1). The PH domain interacts mainly with switch 1, while
the long aCter helix is aligned along the interswitch b sheet,
making hydrophobic contacts with switches 1 and 2 (Me´ne´trey
et al., 2007). Mutagenesis and binding studies confirm that
both the PH domain and the aCter helix centered around
Tyr999 and Ile1053 residues, respectively, are essential for the
binding of ARHGAP21-ArfBD to ARF1 and for recruitment of
ARHGAP21 to Golgi membranes (Me´ne´trey et al., 2007).
ARF6:CT
The cholera toxin (CT) of Vibrio cholerae, the major bacterial
agent of severe diarrheal diseases, is composed of a globular
A subunit, which is cleaved to give rise to an enzymatic A12010 Elsevier Ltd All rights reserved 1553
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cell-translocation B subunit. CT-A1 is an ADP-ribosyltransferase
that catalyzes the covalent transfer of an ADP-ribose moiety
from NAD to Arginine 201 of the stimulatory G protein a subunit
(GSa). ADP-ribosylation of GSa results in elevated intracellular
cAMP levels, which provokes the loss of water and electrolytes
that is typical of diarrheaa (Vanden Broeck et al., 2007). CT-A1
by itself has relatively low activity in vitro, but its affinity and enzy-
matic activity toward its GSa is increased upon interaction with
GTP-bound Arfs of the host cell (Kahn and Gilman, 1986). The
crystal structure of ARF6:CTA1 complex shows that the Arf-
binding site of CT-A1 consists of loop regions with little
secondary structure that rearrange to form an amphipathic helix
upon binding ARF6-GTP (O’Neal et al., 2005). CT-A1 binds to the
switch and interswitch regions of ARF6 predominantly through
hydrophobic interactions (Figure 1).
ARF6:JIP4
c-Jun-N-terminal-kinase (JNK)-interacting protein 3 (JIP3, also
known as MAPK8IP3, JSAP1, and SYD2) and the related JIP4
protein (also known as JLP, SPAG9, and SYD1) interact
specifically with the GTP-bound form of ARF6, but not with
class-I and -II Arfs (Montagnac et al., 2009). Interestingly, ARF6
binding to JIP3 (or JIP4) was found to regulate JIP’s interaction
with kinesin-1 or dynein/dynactin motors; i.e., ARF6-GTP bound
to JIP3/4 favors JIP’s associationwith dynactin, while it interferes
with binding of kinesin-1, leading to the control of endosome
recycling to the plasma membrane (Montagnac et al., 2009).
The interaction of ARF6-GTP involves the second leucine zipper
(LZII) domain of JIP3 andJIP4.Wehave recently solved the struc-
ture of the LZII domain of JIP4 in complex with ARF6-GTP,
revealing that the long and rigid coiled-coil of JIP4LZII interacts
with the interswitch and switch 2 regions of ARF6 (Isabet et al.,
2009) (Figure 1). This structure enlightens, for the first time, how
a specific effector can discriminate between two Arfs, ARF6
and ARF1. Although the crystal is composed of an ARF6-
(JIP4)2-ARF6 heterotetramer with dyad symmetry, a structure-
derived model of the association of the ARF6:JIP4 complex
with membranes suggests that only one membrane-anchored
ARF6 molecule may associate to JIP4, leading to a ARF6-
(JIP4)2 heterotrimeric complex at the plasma membrane (Isabet
et al., 2009).
ARL1:golgin-245
Golgins are a family of large Golgi-localized proteins with
extended coiled-coil regions (up to 200 nm in length) that play
a role in tethering cisternae,transport vesicles to Golgi
membranes, and maintain overall structure of the Golgi complex
(Short et al., 2005). The majority of golgins associate with Golgi
membranes by interactingwith small Gproteins (of theRab family
and theArf orArl groups) in theirGTP-boundstate through related
C-terminal GRIP or GRIP-related Arf-binding (GRAB) domains
(Gillingham et al., 2004; Panic et al., 2003). The golgin-245
GRIP domain binds selectively to ARL1-GTP and not to other
Arf family proteins such as ARF1/ARF6 or ARL2 (Short et al.,
2005). The crystal structure of ARL1:golgin-245GRIP reveals that
the GRIP domain of golgin-245, consisting of an array of three
antiparallel helices (Figure 1), forms a tight homodimer that
binds in a diad symmetric fashion to two ARL1-GTP molecules
(Panic et al., 2003; Wu et al., 2004) (in Figure 1, the quaternary
organization is not shown). Of note, the ARL1-(GRIP)2-ARL11554 Structure 18, December 8, 2010 ª2010 Elsevier Ltd All rights reheterotetramer organization is similar to the one observed for
the ARF6-JIP4LZII complex in the crystal and in solution (Isabet
et al., 2009) and for other small G proteins from the Rab family
(Kawasaki et al., 2005). The interaction of golgin-245 with ARL1
is mediated by two adjacent helices of the GRIP domain, which
align along the b sheet of the interswitch and recognize switch
1andswitch 2, respectively,mainly throughhydrophobic interac-
tions (Figure 1). Thus, the mode of binding of ARL1:golgin-
245GRIP resembles that of ARF1:GGA1N-GAT, with two antiparallel
helices forming predominantly hydrophobic interactions with
switches 1 and 2 and the interswitch regions.
ARL2:PDEd
The regulatory delta subunit of rod-specific cyclic GMP phos-
phodiesterase type 6 (PDEd) interacts with ARL2- and ARL3-
GTP, probably serving as an effector for these proteins
(Hanzal-Bayer et al., 2002, 2005). In photoreceptor cells, PDEd
translocates the enzymatic a and b subunits of PDE6 from
membranes to the cytosol by binding to their prenylated
C termini (Cook et al., 2000). More generally, PDEd can interact
with several prenylated Ras-related G proteins, including
H-Ras, and a role as transport factor for these proteins has
been proposed with ARL2-GTP acting as a regulator of PDEd-
mediated transport (Hanzal-Bayer et al., 2002). In support to
this hypothesis, PDEd features an immunogloblin-like b sandwich
fold with a hydrophobic pocket that could accommodate a lipid
moiety (Hanzal-Bayer et al., 2002). This structure is most similar
to that of RhoGDI (Hoffman et al., 2000), which extracts C-termi-
nally prenylated Rho GTPases from membranes (Olofsson,
1999). In the crystal structure of the ARL2:PDEd complex, the
interface is formed primarily by a parallel inter-protein b sheet
interaction involving b2 of the interswitch region of ARL2 and
b7 of PDEd, resulting in a 10-stranded b sheet extending over
both molecules (Figure 1). Additionally, PDEd interacts with the
switch 2 and interswitch regions of ARL2 in a hydrophobic
manner, with Ile98 of PDEd located between the two switch
regions. Of note, this mode of binding is completely different
from the one observed in the Rho:RhoGDI complex (Hoffman
et al., 2000).
ARL2:BART
Binder of ARL Two (BART) was the first ARL2 effector identified
(Sharer and Kahn, 1999). BART was later shown to be involved
in mitochondria transport and apoptosis (Sharer et al., 2002). It
is also essential for nuclear retention of signal transducers and
activators of transcription 3 (STAT3), and ARL2 binding to BART
enhances the interaction of BART with STAT3 (Muromoto et al.,
2008). However, it remains unclear how BART participates in
these biological processes and what the underlyingmechanisms
are. The crystal structure of the ARL2:BART complex shows that
BART consists of a six a helix bundle that interacts with ARL2-
GTP through two interfaces (Zhanget al., 2009) (Figure 1). Thefirst
interface involves both hydrophobic and hydrophilic interactions
between the switch regions (primarily switch 1) of ARL2 and theN
terminus of helix a3 and the following loop of BART. The second
interface involves extensive hydrophobic interactions between
the N-terminal amphipatic helix of ARL2 and the hydrophobic
cleft formedby helicesa3,a4, anda5 of BART. Thedirect interac-
tion between the N-terminal a helix of ARL2 and BART is unique,
revealing for the first time that the N-terminal helix can be an
essential structural determinant contributing to Arf family:effectorserved
Figure 2. The Common Hydrophobic Area
of the Arf Family Proteins
(A) A cartoon representation of ARF1-GDP (left)
and ARF1-GTP (center) are shown and compared
with the switch regions indicated in dark gray and
the CHA in color (switch 1 part, in blue; interswitch
part, in green; switch 2 part, in red). A detailed view
(right) of the CHA is shown in ribbons, with the resi-
dues forming this region indicated in sticks.
(B) A surface representation of the ARF1-GDP (left)
and ARF1-GTP (right) highlighted the CHA, shown
with the same code color as in (A).
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pathic helix of ARL2 should preclude the ARL2:BART complex
to associating with membranes. This domain is also a site of
specificity since theLLXILmotif in theARL2N-terminal extension,
conserved in ARL3 that also bindsBART, is critical for the binding
of BART (Zhang et al., 2009).
Defining Unified Structural Determinants
for Arf-Family:Effector Binding and Specificity
A striking observation arising from the comparison of these
different Arf family:effector complexes is that Arf family proteins
are recognized by structurally distinct partners consisting of
a-helical fragments (coiled-coil, helix-turn-helix, or helix bundles)
and b sheet or loops, and these domains can be tight or flexible
regions (Figure 1). Thus, it is difficult to predict Arf-binding
domains or anticipate their mode of binding just based on
sequence or structural data.Other information revealed by the
examination of the seven Arf family:effector complex structures
is that the Arf componentsmaintain a rigid structure independent
of their binding partners (Figure 1). Overall, the structure of Arf-
GTP bound to its effector is nearly identical to that of isolated
Arf-GTP or in other Arf-family:effector complexes (as observed
for ARF1, ARF6, and ARL2) with an average root-mean-square
deviation (rmsd) less than 0.6 A˚ over all Ca atoms. Overall, these
observations highlight the capability of the Arf family proteins to
interact with cellular partners different in structures using limited
regions with rigid structure.
A Common Hydrophobic Area
One interesting observation, previously pointed out by O’Neal
et al. (2005) and now confirmed in light of new Arf family:effector
complex structures, is that all these effectors bind to a ±480 A˚2
common hydrophobic area (CHA) on Arf family proteins
(Figure 2). CHA is found at the interface of the switch 1, inter-
switch, and switch 2 regions and it consists of nine residues:
Ile49-Gly50 from the switch 1, Phe51, Val53 and Trp66 from
the interswitch, and Ile74, Leu77 and His80-Tyr81 from theStructure 18, December 8, 2010 ªswitch 2 (unless specified, amino-acid
numbering is that of ARF1) (Figure 2A).
CHA is only exposed in the GTP-bound
form, as it is partially covered by switch
1 in the GDP-bound form (Figure 2B).
Despite strong divergence of effector
structures (Figure 1), interactions made
with CHA are quite similar, involving ±9
hydrophobic residues in the Arf-binding
domain of different effectors. Indeed,while in JIP4LZII the hydrophobic residues are provided by two
parallel helices from two monomers, in GGA1N-GAT and golgin-
245GRIP they originate from two antiparallel helices within the
same molecule. Of note, GGAN-GAT and golgin-245GRIP exhibit
a related helix-turn-helix Arf-binding motif, except in the helix
polarity. In contrast, in ARHGAP21ArfBD, only one helix provides
the hydrophobic residues. On the other hand, and despite the
fact that BART folds as an a helix bundle, its hydrophobic resi-
dues are mainly provided by tight loops, while in CTA1 they
belong to disordered loops. Finally, in PDEd, these residues
are provided by b strands. These observations highlight that
Arf effectors, although not sharing related tertiary structures,
share a similar mode of binding to their cognate Arf family
proteins.
The Hydrophobic Pocket
Belonging to the CHA, the hydrophobic pocket (Figure 3) was
initially identified as a structural determinant for effector binding
and specificity (Me´ne´trey et al., 2007; Panic et al., 2003). Seven
residues from the CHA contribute to the hydrophobic pocket
surface comprising Ile49-Gly50 from switch 1, Phe51 from inter-
switch, and Ile74, Leu77 and His80-Tyr81 from switch 2. In
addition, two residues, Val68 and Gly69 in the conserved
DVGGQ motif of switch 2, are found at the bottom of the pocket
(Figure 3A). With the exception of complexes involving ARF6 and
despite a variety of folds, a key hydrophobic residue, usually
isoleucine or leucine, from the effector (Ile197 in GGAN-GAT,
Ile1053 of ARHGAP21ArfBD, Ile98 of PDEd, and Leu60 in BART)
directs the hydrophobic pocket of Arf family proteins in
a ‘‘lock-and-key’’-like fashion (Figure 3B and 3C). Noticeably,
in the case of the GRIP domain of golgin-245, this hydrophobic
residue is a tyrosine (Y2177) (Figure 3B and 3C). Mutation of
golgin-245GRIP-Y2177, ARHGAP21ArfBD-Ile1053, or BART-
Leu60 has demonstrated the critical role of this hydrophobic
residue for binding Arf family proteins (Kjer-Nielsen et al., 1999;
Barr, 1999; Me´ne´trey et al., 2007; Zhang et al., 2009). This inter-
action may also confer specificity as in the ARL1:golgin-245GRIP2010 Elsevier Ltd All rights reserved 1555
Figure 3. The Hydrophobic Pocket of the Arf Family Proteins
(A) A surface representation of ARF1-GTP (left) is shown with the switch
regions indicated in dark gray and the hydrophobic pocket in brown. A detailed
view (right) of the hydrophobic pocket is shown in ribbons, with the residues
forming this region indicated in sticks.
(B) A detailed view of the ARF1:ARHGAP21 complex is shown with the aCter
part of ARHGAP21 in cyan and Ile1053 residue in sticks.
(C) The ‘‘lock-and-key’’ interaction between several effectors and the hydro-
phobic pocket of their cognate Arf family proteins are shown superposed.
For clarity, only the surface representation of ARF1-GTP is shown. Effector
parts are shown in ribbons with their key residues indicated in sticks.
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owing to a sequence variation at position 80 in ARL1 as
compared with other Arf family proteins (Panic et al., 2003)
(Figure S1). This modifies the size of the pocket (Figure S2) and
allows ARL1 to accommodate the voluminous tyrosine residue
of golgin-245 more deeply in the hydrophobic pocket
(Figure 3C). Similarly, a deeper positioning of the hydrophobic
key residue is also observed in PDEd and BART that interact
specifically with ARL2/ARL3 (Figure 3C). In this case, an aspara-
gine residue at position 80 of ARL2/ARL3 (Figure S1) accounts
for further opening of the hydrophobic pocket (Figure S2).
Beyond its impact on the size of the hydrophobic pocket, posi-
tion 80 makes also direct contacts with the effectors; thus,
sequence difference at this position in the different Arf family
poteins represents a clear structural determinant for specificity.
Along this line, mutation of Cys80 in ARL1 to a histidine residue
as in Arfs prevents GRIP domain of golgin-245 to interact with
ARL1 (Lu and Hong, 2003). Therefore, despite overall similarity
in the interacting surfaces of Arfs, ARL1, and ARL2/ARL3 with
their effectors, it appears that relatively subtle differences in
the sequence and structure of the hydrophobic pocket are suffi-
cient to confer specific recognition.
Another intriguing observation concerning the hydrophobic
pocket is that the carbonyl group of the last residue of the switch1556 Structure 18, December 8, 2010 ª2010 Elsevier Ltd All rights re1 (Ile49) is found either directed toward or outside the pocket,
owing to dyhedral angle torsion change of an adjacent glycine
residue (Gly50). The two distinct orientations of this carbonyl
group are observed in the GTP-bound form of ARF1, ARF6,
and ARL2, both in or out of complex with their effectors. This
structural difference is expected in all Arfs since this glycine
residue is conserved, except in SAR1A, SAR1B, and ARL13B
(Figure S1). Interestingly, this carbonyl group as well as the
amide group of the adjacent glycine residue both can form inter-
actions with effectors, as observed in ARF1-GGA1N-GAT, ARL2-
PDEd, and ARL2-BART complexes (Hanzal-Bayer et al., 2002;
Shiba et al., 2003; Zhang et al., 2009). Thus, a given Arf family
protein can slightly rearrange its hydrophobic pocket in order
to accommodate different effectors. For example, ARL2 makes
an hydrogen bond through its Leu48-carbonyl group with the
amide group of the Thr102 of PDEd while making an hydrogen
bond through its Gly49-amide group with the carboxylate
group of Glu57 in BART, with different orientations of the
Leu48-carbonyl group in these two ARL2:effector complexes
(Figure S3). Such subtle differences certainly represent impor-
tant structural determinants supporting the capacity of a given
Arf family protein to interact and recognize a variety of structur-
ally diverse effectors.
A Hydrophobic Triad
Another region belonging to the CHA consists in a hydrophobic
triad comprised of Phe51, Trp66, and Tyr81 of interswitch and
switch 2 regions (Figure 4A). Of note, both Phe51 and Tyr81
are also part of the hydrophobic pocket that is adjacent to the
hydrophobic triad. Overall, this triad is involved in hydrophobic
interactions with one to three hydrophobic residues from the
effector, but in contrast to the specific ‘‘lock-and-key’’ interac-
tion between the effector and the hydrophobic pocket of Arf
family proteins described above; no similitude in the residue
position and nature are observed. We previously proposed that
this region is important for Arf effector binding (Me´ne´trey et al.,
2007). Indeed, in the ARL1:golgin-245GRIP complex, the
hydrophobic triad of ARL1 makes interaction with the Met2194
of golgin-245 (Figure 4B); mutation of Met2194 to alanine
abolishes ARL1-mediated targeting of golgin-245 to Golgi
membranes (Wu et al., 2004), revealing that the hydrophobic
triad, as the hydrophobic pocket, plays a critical role for effector
binding. An isoleucine residue in ARGHAP21 (Ile1057) is found at
a related position (Figure 4B), suggesting similar roles.Moreover,
the triad is strictly conserved in Arfs, ARL1, and ARL2/ARL3,
suggesting no role in effector discrimination between these
proteins. However, sequence differences are observed with
other members of the Arf family proteins, mainly at position
Phe51 and Trp66. For instance, serine and proline residues are
found in place of Phe51 in ARL5 and SAR isoforms, respectively,
while basic or leucine residues replace Trp66 in ARL15/ARL16
and ARL9/ARL10, respectively (Figure S1). This suggests that,
as for the hydrophobic pocket, the hydrophobic triad may also
be a structural determinant for Arf family protein discrimination
by specific effectors.
Strikingly, Rab proteins also possess a hydrophobic triad,
which was proposed to be a major structural determinant for
effector binding and specificity (Merithew et al., 2001). Sequence
and position of the hydrophobic triads are conserved in Rab and
Arf families, except for the phenylalanine that is found at the n+2served
Figure 4. The Hydrophobic Triad of the Arf Family Proteins
(A) A surface representation of ARF1-GTP (left) is shown with the switch regions indicated in dark gray and the hydrophobic triad in yellow. A detailled view (right)
of the hydrophobic triad is shown in ribbons, with the residues forming this region indicated in sticks.
(B) A superposition of the ARL1:golgin-245GRIP (green) and ARF1:ARHGAP21ARFBD (cyan) complexes is shown. For clarity, only the ARF1-GTP is indicated, with
its switch in dark gray and residues forming the hydrophobic triad in yellow. Golgin-245 and ARHGAP21 are shown in ribbons, with their hydrophobic residues
facing the hydrophobic triad in sticks.
Structure
Minireviewposition in Rab proteins (Figure S4). Of note, the phenylalanine
residue in Rab proteins is replaced by a smaller hydrophobic
residue in Arf family proteins that belongs to the CHA and is
involved in direct interaction with effectors. In contrast to Arf
family proteins, the hydrophobic triad is conserved in sequence
within the Rab subgroup, but exhibits different side-chain
rotamers that confer specificity to effector recognition (Merithew
et al., 2001).
Structural Determinants for ARF1/ARF6 Discrimination
We recently reported the crystal structure of ARF6 in complex
with its specific effector JIP4 (Isabet et al., 2009). Although struc-
tural comparison of ARF6 and ARF1 in the region of interface
with JIP4 revealed no major structural difference in the main-
chain conformation that might account for JIP4’s specificity,
sequence differences between the two Arfs were observed
that confer specificity (Isabet et al., 2009). These sequence
differences are located at the edge of the switch regions, outsideFigure 5. Structural Basis of JIP4 Specificity for ARF6
The ARF6:JIP4LZII complex structure is shown with the switch regions of
ARF6-GTP in dark grey and the CHA in color. JIP4 is indicated in yellow/orange
ribbons. Sequence differences between ARF1 and ARF6 in the switch region
are indicated by spheres. The four sequence differences outside the CHA
that are the structural determinants for JIP4 specificity are highlighted in
orange.
Structurethe CHA, more precisely at the extremities of the interswitch and
switch 2 regions (Figure 5). All together, these observations
suggest that nonconserved residues at the edge of the switch
regions are key structural determinants for effector specificity.
Recently, the structure of ARL2:BART complex has revealed
that the N-terminal helix of Arf family proteins can also contribute
to effector binding and specificity (Zhang et al., 2009). Sequence
differences between the N-terminal helices of ARF1 and ARF6
exist (Figure S1); these could also contribute to some effector
discrimination between ARF1 and ARF6. Although, in the GTP-
bound form the hydrophobic face of the N-terminal helices of
ARF1 and ARF6 are involved in membrane interactions (Antonny
et al., 1997; Liu et al., 2010), their hydrophilic faces are suppos-
edly free and thus could make interactions with effectors. All
together, these findings highlight that effectors can interact
and recognize the entire switch regions of Arf family proteins.
Other structures of ARF1/ARF6 proteins in complex with specific
effectors will be necessary to generalize and refine our conclu-
sions concerning Arf family:effector interactions.
Conclusion
Based on available structural information, we can infer that the
hydrophobic pocket and hydrophobic triad are key structural
determinants for effectors to discriminate between different
groups of Arf family proteins. However, in Arfs (ARF1-6), these
two structural determinants are rather conserved in sequence
and do not confer specificity, which rather involves variable resi-
dues located outside the hydrophobic common area, at the edge
of the switch region or within the N-terminal helix.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and can be found with this
article online at doi:10.1016/j.str.2010.11.004.
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